Genentech

HEMLIBRA

Manufacturer:

Genentech

Hemlibra HCPCS:

J7170

HCPCS Code Descriptor:

Injection, emicizumab-kxwh, 0.5 mg

Category:

J Code

Hemlibra NDCs:

50242-0927-01, 50242-0920-01, 50242-0922-01, 50242-0921-01, 50242-0923-01, 50242-0930-01

Primary Type:

Hematology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Subcutaneous

Hemlibra CPT Codes:

Potential CPT administration codes for Hemlibra can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Hemlibra:

HEMLIBRA is a Hematology drug manufactured by Genentech and administered via the Subcutaneous route of administration. The J Code: J7170 is aligned to the drug HEMLIBRA.

ACCESS PRICING AND MORE BY REGISTERING

J7170 Added Date:

January 1, 2019

J7170 Effective Date:

January 1, 2019

J7170 Termination Date:

HCPCS Active

Hemlibra billing and coding information can be found through Genentech at the link below:
Hemlibra patient assistance information can be found through Genentech at the URL: https://www.gene.com/patients/patient-foundation
HEMLIBRA prescribing information can be found at the link below:
Information regarding HEMLIBRA’s side effects can be found at MedlinePlus